Skip to content

    Pain Management Health Center

    Font Size
    A
    A
    A

    FDA Warns Firms Selling Unapproved Drugs

    9 Prescription Narcotics Makers Are New Target of FDA Push
    By
    WebMD Health News
    Reviewed by Louise Chang, MD

    March 31, 2009 -- Nine drug companies selling 14 prescription narcotics are the latest target of the FDA's effort to bring thousands of unapproved drugs under FDA scrutiny.

    The drugs aren't known to be unsafe. But because the drugs are sold without FDA approval, the agency has no way of knowing whether they are made safely, contain labeled ingredients, or carry correct dosages, says Deborah Autor, JD, director of the office of compliance at FDA's Center for Drug Evaluation and Research.

    "Companies owe it to patients to ensure their drugs are legally marketed," Autor said at a news conference. "Today's action is about ensuring Americans have safe and effective drugs and getting the message to companies that they have a responsibility to patients."

    The FDA is giving the firms 15 days to respond to its warning. The firms have 60 days to stop making the unapproved drugs and 90 days to stop distributing them. What happens after that?

    "They will be subject to immediate enforcement actions," Autor said. "One company's violation of our deadline resulted in seizure of $24 million of their unapproved drugs."

    Firms may claim that their drugs are "legacy" or "grandfathered" drugs that were on the market before FDA regulations took effect. But Autor said the FDA believes there is no such thing as a legacy drug and that very few drugs actually fall under the grandfather clause.

    The 14 drugs targeted today are high concentrate morphine sulfate oral solutions and immediate-release tablets containing morphine sulfate, hydromorphone, or oxycodone. No oxycodone capsules are involved in the action.

    The firms and drugs subject to today's FDA warning letters are:

    Firms

    Products

    Mallinckrodt Inc. Pharmaceuticals Group

    Morphine Sulfate Concentrate Oral Solution 20 mg/mL

    Boehringer Ingelheim Roxane Inc.

    Roxanol Oral Solution, 20 mg/mL;
    Roxicodone Tablets, 5 mg

    Roxane Laboratories Inc.

    Hydromorphone Hydrochloride Tablets, 2 mg and 4 mg

    Glenmark Generics Inc.

    Morphine Sulfate Tablets, 15 mg & 30 mg;
    Morphine Sulfate Solution Immediate Release Concentrate, 20 mg/mL;
    Morphine Sulfate Solution Immediate Release Oral Solution, 20 mg/5 mL

    Lannett Company Inc.

    Morphine Sulfate Solution Immediate Release 20 mg/mL;
    Hydromorphone HCl Tablets, 2 mg and 4 mg

    Lehigh Valley Technologies Inc.

    Morphine Sulfate Tablets, 15 mg & 30 mg;
    Morphine Sulfate Solution Concentrate, 20 mg/mL

    Physicians Total Care Inc.

    Morphine Sulfate Immediate Release Tablets, 30 mg;
    Hydromorphone Tablets, 2 mg;
    Hydromorphone Hydrochloride Tablets 4 mg

    Xanodyne Pharmaceuticals Inc.

    Roxanol Oral Solution, 20 mg/mL;
    Roxicodone Tablets, 5 mg

    Cody Laboratories Inc.

    Morphine Sulfate Solution Immediate Release 20 mg/mL

    Today on WebMD

    pain in brain and nerves
    Top causes and how to find relief.
    knee exercise
    8 exercises for less knee pain.
     
    acupuncture needles in woman's back
    How it helps arthritis, migraines, and dental pain.
    chronic pain
    Get personalized tips to reduce discomfort.
     
    illustration of nerves in hand
    Slideshow
    lumbar spine
    Slideshow
     
    Woman opening window
    Slideshow
    Man holding handful of pills
    Video
     
    Woman shopping for vegetables
    Slideshow
    Sore feet with high heel shoes
    Slideshow
     
    acupuncture needles in woman's back
    Slideshow
    man with a migraine
    Slideshow